IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.025
AS - Asia 3.044
EU - Europa 2.950
SA - Sud America 791
AF - Africa 146
OC - Oceania 4
AN - Antartide 1
Totale 13.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.929
SG - Singapore 1.173
RU - Federazione Russa 923
CN - Cina 867
IT - Italia 655
BR - Brasile 624
SE - Svezia 398
HK - Hong Kong 334
DE - Germania 221
UA - Ucraina 209
VN - Vietnam 180
FI - Finlandia 170
FR - Francia 137
IN - India 105
GB - Regno Unito 98
CI - Costa d'Avorio 80
BD - Bangladesh 76
AR - Argentina 61
ID - Indonesia 46
CA - Canada 42
IQ - Iraq 36
TR - Turchia 31
MX - Messico 30
CO - Colombia 29
EC - Ecuador 25
PK - Pakistan 25
JP - Giappone 24
SA - Arabia Saudita 24
ZA - Sudafrica 23
ES - Italia 20
PH - Filippine 20
VE - Venezuela 20
BE - Belgio 18
UZ - Uzbekistan 18
IE - Irlanda 17
JO - Giordania 13
PL - Polonia 13
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
NL - Olanda 10
TN - Tunisia 10
CL - Cile 9
PE - Perù 8
BO - Bolivia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
EG - Egitto 6
LT - Lituania 6
PY - Paraguay 6
SN - Senegal 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
AL - Albania 4
JM - Giamaica 4
KZ - Kazakistan 4
MA - Marocco 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
CR - Costa Rica 3
GE - Georgia 3
MY - Malesia 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KR - Corea 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
TH - Thailandia 2
UY - Uruguay 2
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
Totale 13.955
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Ashburn 583
Woodbridge 577
Singapore 572
Jacksonville 461
Houston 372
San Jose 371
Hong Kong 332
Nyköping 327
Seattle 269
Ann Arbor 255
Milan 247
Cambridge 244
Beijing 213
Wilmington 213
Nanjing 141
Bari 136
New York 131
Lawrence 130
Roxbury 128
Lauterbourg 110
Boardman 89
Rome 89
Des Moines 84
Abidjan 80
Los Angeles 80
Dallas 77
Ho Chi Minh City 72
Helsinki 66
Princeton 57
Inglewood 55
Columbus 49
São Paulo 47
Brooklyn 44
Santa Clara 43
Nanchang 42
Buffalo 41
Hebei 39
Council Bluffs 35
Shenyang 33
Jiaxing 32
San Diego 32
Dearborn 29
Hanoi 29
Munich 25
Pune 24
Tokyo 24
Guangzhou 20
San Francisco 19
Tianjin 19
Moscow 18
Turin 18
Baghdad 17
Belo Horizonte 17
Brussels 17
Dublin 17
Jakarta 17
Shanghai 17
The Dalles 17
Figino 16
Rio de Janeiro 16
Tashkent 16
Changsha 14
Toronto 14
Amman 13
Boston 13
Frankfurt am Main 13
Ardabil 12
Brasília 12
London 12
Orem 12
Brno 11
Chicago 11
Falkenstein 11
Medellín 11
Montreal 11
Mumbai 11
Phoenix 11
Salvador 11
Atlanta 10
Auburn Hills 10
Chennai 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
Quito 10
Washington 10
Bologna 9
Dhaka 9
Jinan 9
Ningbo 9
Riyadh 9
Santo André 9
Warsaw 9
Wuhan 9
Curitiba 8
Jeddah 8
Ribeirão Preto 8
Totale 9.015
Salva come PNG Salva come JPEG
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 722
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 226
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 202
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 186
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 184
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 183
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 180
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 179
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 171
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 164
Effect of chirality in platinum drugs 161
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 158
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 156
Mutagenic activity of some platinum complexes: chemical properties and biological activity 154
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 154
Biologic activity of platiunum complexes with proflavine 148
Endothelial cells in the bone marrow of patients with multiple myeloma 138
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 137
Antitumour platinum iminoether complexes 130
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 130
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 129
Platinum(II) based anticancer agents with a trans geometry 125
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 124
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 123
Antitumour platinum iminoether complexes 123
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 123
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 123
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 122
Antitumour ruthenium(II)-dimethylsulfoxide complexes 121
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 120
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 120
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 119
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 119
Antitumour platinum-iminoether complexes 118
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 118
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 118
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 117
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 117
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 115
Antitumor active trans-platinum compounds 115
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 113
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 113
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 111
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 111
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 110
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 110
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 109
Antitumor activity of trans platinum complexes 109
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 107
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 106
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 106
null 104
Current Status of trans-Platinum Compounds in Cancer Therapy 102
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 101
Anttitumor activity of trans-platinum species 101
Trans-Platinum Complexes in Cancer Therapy 99
In vitro cisplatin effects on phagocyte functions 99
A trans-platinum complex showing higher antitumor activity than the cis congeners 99
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 99
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 98
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 97
Bone Marrow Fibroblasts and Multiple Myeloma Progression 96
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 96
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 95
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 94
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 93
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 92
null 92
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 91
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 91
Complessi antitumorali di platino a geometria trans 91
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 90
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 89
null 88
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 88
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 87
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 86
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 84
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 84
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 83
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 81
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 81
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 80
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 80
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 79
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 79
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 79
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 78
Screening tests for selecting anticancer metal compounds 78
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 78
The IS-BioBank project: a framework for biological data normalization, interoperability, and mining for cancer microenvironment analysis 77
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 75
A new generation of platinum anticancer complexes with trans geometry 75
Complessi antitumorali di platino a geometria trans 74
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 73
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 72
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 72
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 72
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 72
DNA interaction properties of platinum –iminoether complexes 69
Totale 11.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20264.851 564 172 335 486 490 229 434 105 1.105 350 111 470
2026/202798 98 0 0 0 0 0 0 0 0 0 0 0
Totale 14.270